(Q73758085)
Statements
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) (English)
Bornhäuser M
Zander AR
Kröger N
Schleuning M
Finke J
Zabelina T
Beelen D
Schwerdtfeger R
Baurmann H
Fauser AA
Kiehl M
Trenschel R
Ottinger HD
Bertz H
Berger J
Kolb HJ
1 August 2003